The estimated Net Worth of Stephen K. M.D. Klasko is at least $2.1 Milhão dollars as of 13 December 2023. Stephen Klasko owns over 3,021 units of Teleflex stock worth over $1,854,516 and over the last 17 years he sold TFX stock worth over $0. In addition, he makes $247,537 as Independent Director at Teleflex.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Stephen Klasko TFX stock SEC Form 4 insiders trading
Stephen has made over 33 trades of the Teleflex stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 3,021 units of TFX stock worth $305,484 on 13 December 2023.
The largest trade he's ever made was exercising 5,200 units of Teleflex stock on 12 May 2017 worth over $292,968. On average, Stephen trades about 349 units every 41 days since 2008. As of 13 December 2023 he still owns at least 7,584 units of Teleflex stock.
You can see the complete history of Stephen Klasko stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Stephen Klasko biography
Dr. Stephen K. Klasko M.D. serves as Independent Director of the Company. Since June 2013, he has been the President and Chief Executive Officer of Thomas Jefferson University and Jefferson Health. From September 2004 to June 2013, Dr. Klasko served as Dean of the College of Medicine of the University of South Florida. From 2009 to June 2013, Dr. Klasko also served as the Chief Executive Officer of USF Health, which encompasses the University of South Florida’s colleges of medicine, nursing and public health. He was a Vice President of USF Health from 2004 to 2009. Dr. Klasko served as Dean of the College of Medicine of Drexel University from 2000 to 2004.
What is the salary of Stephen Klasko?
As the Independent Director of Teleflex, the total compensation of Stephen Klasko at Teleflex is $247,537. There are 15 executives at Teleflex getting paid more, with Liam Kelly having the highest compensation of $6,782,760.
How old is Stephen Klasko?
Stephen Klasko is 66, he's been the Independent Director of Teleflex since 2008. There are 1 older and 16 younger executives at Teleflex. The oldest executive at Teleflex Incorporated is George Babich, 68, who is the Lead Independent Director.
What's Stephen Klasko's mailing address?
Stephen's mailing address filed with the SEC is 550 E SWEDESFORD ROAD, SUITE 400, WAYNE, PA, 19087.
Insiders trading at Teleflex
Over the last 21 years, insiders at Teleflex have traded over $16,880,558 worth of Teleflex stock and bought 4,250 units worth $1,104,860 . The most active insiders traders include Gretchen R Haggerty, W Kim Foster, eBenson Smith. On average, Teleflex executives and independent directors trade stock every 22 days with the average trade being worth of $1,065,906. The most recent stock trade was executed by Stuart A Randle on 16 August 2024, trading 2,674 units of TFX stock currently worth $323,554.
What does Teleflex do?
teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. headquartered in wayne, pa, teleflex employs approximately 12,000 people worldwide and serves healthcare providers in more than 150 countries.
What does Teleflex's logo look like?
Complete history of Stephen Klasko stock trades at Teleflex
Teleflex executives and stock owners
Teleflex executives and other stock owners filed with the SEC include:
-
Liam Kelly,
Chairman of the Board, President, Chief Executive Officer -
Thomas Powell,
Chief Financial Officer, Executive Vice President -
Liam J. Kelly,
Chairman, Pres & CEO -
James Leyden,
Corporate Vice President, General Counsel, Secretary -
Cameron Hicks,
Corporate Vice President - Human Resources and Communications -
Thomas E. Powell,
Exec. VP & CFO -
Karen Boylan,
Vice President - Global Strategic Projects -
James P. Winters,
Corp. VP, Manufacturing and Supply Chain -
Cameron P. Hicks,
Corp. VP & Chief HR Officer -
John Heinmiller,
Independent Director -
George Babich,
Lead Independent Director -
Candace Duncan,
Independent Director -
Stuart Randle,
Independent Director -
Andrew Krakauer,
Independent Director -
Gretchen Haggerty,
Independent Director -
Stephen Klasko,
Independent Director -
Richard Packer,
Independent Director -
James Winters,
Corporate Vice President - Manufacturing and Supply Chain -
Mario Wijker,
Corporate Vice President - QA/RA -
Jake Elguicze,
Treasurer and Vice President Investor Relations -
James Ferguson,
Pres & GM of Surgical -
Howard Cyr,
Corp. VP & Chief Compliance Officer -
Daniel V. Logue,
Corp. VP, Gen. Counsel & Sec. -
John Hsu C.F.A.,
VP of Investor Relations -
Timothy F. Duffy,
VP & Chief Information Officer -
John R. Deren,
Corp. VP & Chief Accounting Officer -
W Kim Foster,
Director -
Thomas Anthony Kennedy,
Senior VP, Global Operations -
Patricia C Barron,
Director -
Jeffrey A Graves,
Director -
William Roland Cook,
Director -
Benson Smith,
Director -
Richard A Meier,
Exec. Vice Pres. and CFO -
James W Zug,
Director -
Charles Edward Williams,
Corp. Controller and CAO -
John B Suddarth,
President-Aerospace -
Jeffrey P Black,
President, CEO -
Vincent Northfield,
President - Commercial -
R Ernest Waaser,
President - Medical -
Harold L Iii Yoh,
Director -
Sigismundus W W Lubsen,
Director -
Seldeneck Judith M Von,
Director -
Matthew J Jennings,
Sr. VP, Corp. Development -
Kevin K Gordon,
Vice Pres. Corporate -
Julie Mcdowell,
Sr. VP Corp. Communic. -
John J Sickler,
Vice Chairman -
Randall P Gaboriault,
Sr. Vice Pres. & Chf Info Off -
Laurence G Miller,
Sr.VP, General -
Forrest R Whittaker,
President - Medical -
James W Eug,
Director -
Steven Kent Chance,
Vice Pres., General -
James W Stratton,
Director -
Clark D Handy,
Exec.Vice Pres. -
Martin S Headley,
Exec. Vice Pres. -
Lennox K Black,
Non-Executive -
James V Agnello,
Corporate Controller -
Donald Beckman,
Director -
Joan W Schwartz,
Assoc.Gen'l Counsel -
Thomas M Byrne,
Assistant Treasurer -
Joseph S Gonnella,
Director -
C Jeffrey Jacobs,
Treasurer -
Harold L Jr Zuber,
Exec. Vice Pres. and -
Janine Dusossoit,
-
Jaewon Ryu,
Director -
Jay White,
CVP & Pres, Global Commercial -
John Deren,
Corp. VP & CAO -
Daniel V. Logue,
CVP, General Counsel & Secty -
Neena M Patil,
Director